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Alcoholism is a pervasive societal problem, yet available pharmacotherapies fail to treat 
most sufferers. The type 1 corticotropin-releasing factor (CRF1) receptor has received 
much attention for its putative role in the progression to alcohol dependence, although 
at present its success in clinical trials has been limited. Two single-nucleotide polymor-
phisms in the rat Crhr1 promoter have been identified in the Marchigian substrain of 
Sardinian alcohol-preferring (msP) rats. Unlike other Wistar-derived alcohol-preferring 
lines, nondependent msP rats reduce their alcohol self-administration in response to 
CRF1 antagonists and show increased brain CRF1 expression. The current study tested 
the hypotheses that the A alleles in the Crhr1 promoter polymorphisms are: (1) unique 
to msP (vs. CRF1 antagonist-insensitive) alcohol-preferring lines and (2) associate with 
greater alcohol preference or intake. Two related polymorphisms were observed in which 
both loci on a given chromosome were either mutant variant (A) or wild-type (G) alleles 
within the distal Crhr1 promoter of 17/25 msP rats (68%), as compared to 0/23 Indiana 
P rats, 0/20 Sardinian alcohol-preferring rats bred at Scripps (Scr:sP) and 0/21 outbred 
Wistar rats. Alcohol consumption in msP rats did not differ according to the presence 
of Crhr1 A alleles, but greater alcohol preference (98%) was observed in A allele homo-
zygous msP rats (AA) compared to msP rats with wild-type (GG, 91%) or heterozygous 
(GA, 91%) genotypes. The greater alcohol preference reflected decreased water intake, 
accompanied by reduced total calories consumed by AA rats. The data show that msP 
rats differentially possess mutant A variant alleles in the polymorphic promoter region of 
the Crhr1 gene that may differentially regulate consumption.
Keywords: alcohol, ethanol, corticotropin-releasing factor, corticotropin-releasing hormone, promoter, single-
nucleotide polymorphism, genetic vulnerability, selective breeding
inTrODUcTiOn
Alcohol abuse and dependence affect about 8% of the population worldwide (1), generating signifi-
cant societal costs (2). Despite this major public health burden, available pharmacotherapies for 
alcohol use disorders remain inadequate. Toward developing new therapeutic targets, rodent lines 
have been selectively bred for differential propensity to consume alcohol. The characterization of 
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genetic differences in these lines may identify new molecular 
targets for medications development.
One target implicated in the progression and persistence of 
alcohol dependence is corticotropin-releasing factor (CRF), a 
peptide upregulated and released in the extended amygdala dur-
ing alcohol withdrawal (3–6). Alcohol dependence confers sen-
sitivity to CRF1 antagonists to reduce alcohol self-administration 
(7–9), similarly to binge-like alcohol consumption observed in 
intermittent access (10–13) and “Drinking in the Dark” (DID) 
paradigms (14–17). Blockade of CRF1 does not typically alter 
alcohol intake in nondependent rodents consuming alcohol in 
non-binge-like patterns (7, 13–15). Sensitization of the CRF 
system has been hypothesized to mediate the transition to 
dependence, whereby negative reinforcement (“self-medication”) 
putatively drives high alcohol intake in situations of CRF system 
hyperactivation (18–20). While CRF1 antagonists have so far 
proved largely unsuccessful to treat alcohol use disorders in 
human clinical trials (21, 22), this has been theorized to result 
from individual variation in clinical trial subjects’ drinking 
motivation, such that only a subset of the population, such as 
those engaging in stress-induced drinking, might respond to 
CRF1 antagonist treatment [reviewed in Ref. (23)]. Thus under-
standing the role of CRF in promoting escalated alcohol intake 
in rodent models remains important. The presence of heightened 
CRF system activity in rat lines bred for high alcohol preference 
may recapitulate the behaviors that result from extensive alcohol 
exposure, and consequent recruitment of CRF circuitry, that are 
seen in environmental rodent models of alcohol dependence.
Several alcohol-preferring rat lines have been selectively bred 
from Wistar stock, including the Indiana alcohol-preferring 
[P (24)] and Sardinian alcohol-preferring [sP (25)] lines, as well 
as substrains derived from the sP line, including Marchigian sP 
[msP (26, 27)] and Scripps sP [Scr:sP (9, 28, 29)] rats. Different 
genetic factors may underlie each line’s excessive alcohol drink-
ing. Studies suggest that the lines are not uniform in their CRF/
CRF1 systems. For example, Scr:sP rats show elevated amygdala 
dialysate CRF levels relative to Sardinian non-preferring rats (30), 
and msP rats exhibit increased CRF1 expression in the extended 
amygdala relative to Wistar rats (31, 32). In contrast, P rats show 
reduced CRF expression, as compared to non-preferring rats, 
in the amygdala and cortex (33). Furthermore, despite similarly 
high alcohol intake, only msP rats (31, 34, 35), and not Scr:sP (9) 
or P (36) rats, reduce their basal levels of operant alcohol self-
administration in response to CRF1 antagonists, a trait that may 
result from the msP rats’ elevated basal anxiety (32, 35).
Previously, two single-nucleotide polymorphisms (SNPs) 
were discovered in the distal promoter region of the CRF1 gene 
(Crhr1), with 85% of msP rats vs. 0% of Wistar controls possessing 
an A allele at both polymorphic positions (A allele) vs. the typical 
G allele (31). The variant A allele was hypothesized to contribute 
to the increased CRF1 expression and CRF1 antagonist sensitivity 
of msP rats. However, it remains unknown whether the mutant 
variant A allele is unique to msP rats, relative to other alcohol-
preferring lines (Scr:sP, P). Here, we tested the hypotheses that 
(1) the presence of the variant A allele in the Crhr1 promoter 
region is restricted to the CRF1 antagonist-sensitive msP line 
and (2) the presence of two mutant (A) alleles is associated with 
elevated home cage alcohol intake or preference in the msP line. 
Our results demonstrate that the presence of the A allele is unique 
to the msP strain, and that homozygous expression of the A allele 
(AA) was not differentially associated with elevated baseline 
alcohol consumption in msP rats, although the AA genotype may 
associate with a slight increase in alcohol preference, albeit over 
very high preference levels in all msP rats.
MaTerials anD MeThODs
ethics statement
These studies were carried out in accordance with the recom-
mendations of the European Community Council Directive for 
the Care and Use of Laboratory Animals and the University of 
Camerino Internal Ethical Committee for Laboratory Animal 
Protection and Use (CEAPA), or in accordance with the NIH 
Guide for the Care and Use of Laboratory Animals and The Scripps 
Research Institute Institutional Animal Care and Use Committee 
(IACUC). The protocols were approved by the University of 
Camerino CEAPA and by the Scripps Research Institute IACUC.
animals
Subjects were adult males from two distinct sublines derived from 
the Sardinian preferring (sP) rats—the msP and Scr:sP rats. The 
breeding program of sP rats began in 1981 (University of Cagliari, 
Italy). Beginning with the 13th generation of sP rats, a subset of 
rats was provided to a separate program for selective breeding at 
the University of Camerino, Italy. After 20 generations of selective 
breeding for high alcohol preference, this distinct subline was 
renamed msP (27). The msP rats in the present study (n = 25 for 
the strain comparison and n = 79 for the home cage consumption 
study) were from the 58th–59th generations of selective breeding. 
A rederivation of the msP line, to generate sublines homozygous 
for the G allele (GG) and homozygous for the A allele (AA), was 
performed as described in Ref. (35). Rats from these sublines (n = 9 
GG, n = 8 AA) were used for analysis of food intake when no alco-
hol was available. All behavioral studies, which involved only msP 
rats, were performed at the University of Camerino (Camerino, 
Italy). While these studies only include male subjects, it should be 
noted that sex differences in CRF1 signaling have been reported in 
the locus coeruleus (37) that might increase female responsiveness 
to conditions of altered CRF1 expression, although sex differences 
were not observed following germline Crhr1 deletion (38).
In the 32nd generation of selective breeding of sP rats according 
to high alcohol preference at the University of Cagliari, a subset of 
sP rats were provided by Dr. G. L. Gessa to The Scripps Research 
Institute and maintained as a colony without further selective 
breeding. Rats from this colony were designated as Scr:sP (http://
rgd.mcw.edu/rgdweb/report/strain/main.html?id=2302666). 
The Scr:sP subline, like the sP line from which they were derived 
(39), show high spontaneous home cage alcohol intake (5–7 g/kg 
daily) and preference (>80% vs. water) and display high levels of 
anxiety-like behavior (9, 40). The Scr:sP rats in the present study 
(n = 20) were from the 23rd–24th generations of intra-line breed-
ing at the Committee on the Neurobiology of Addictive Disorders 
of The Scripps Research Institute (La Jolla, CA, USA).
FigUre 1 | Alignment of amplicons used for Crhr1 promoter sequencing. Primer pairs were designed using the Crhr1 promoter sequence obtained from the 
University of California, Santa Cruz genome browser to generate six overlapping amplicons for complete coverage of the promoter region, based in part on 
previously published sequences (31). Chromosomal alignment of the overlapping Crhr1 promoter amplicons is shown relative to (a) the Crhr1 gene sequence and 
(B) the Crhr1 proximal promoter region (based on UCSC Genome Browser, rat assembly July 2014). While consistent with the relative lengths of amplicons 
produced, the visual representation is not drawn to scale.
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For the strain comparison, adult male outbred Wistar rats 
(n = 21) obtained from Charles River (Raleigh, NC, USA) were 
used as controls. In addition, adult male Indiana P rats (41), gen-
erously provided by Dr. L. Lumeng (Indiana University School of 
Medicine, Indianapolis, IN, USA), also were subjects (n = 23) at 
The Scripps Research Institute. P rats have been bred at Indiana 
University School of Medicine since original establishment of 
the line by selective breeding from a Wistar rat colony at the 
Walter Reed Army Hospital (the Walter Reed Wistar rat) (42). 
P rats demonstrate high alcohol intake in the home cage (>5 g/
kg/day) (43), yielding pharmacologically relevant blood alcohol 
levels (44).
Rats were housed under a 12-h reversed light cycle under 
constant temperature (20–22°C) and humidity (45–60%). Rats 
were housed three per cage in standard, wire-topped plastic 
cages containing sawdust bedding, with food (Camerino: 4RF18, 
Mucedola, Settimo Milanese, Italy; Scripps: LM-485 Diet 7012, 
Harlan, Madison, WI, USA) and water available ad libitum. Rats 
for behavioral studies received environmental enrichment prior 
to experimentation, at which time rats were singly housed to 
allow for recording of drinking and food consumption, as detailed 
below. At the conclusion of experiments, rats were euthanized by 
carbon dioxide inhalation.
sequencing of the Crhr1 Promoter
Crhr1 promoters were sequenced in all subjects. For the strain 
comparison, 6 primer pairs were designed to sequence the ~2,300 
bases upstream of the Crhr1 start codon (Figure 1A) and obtained 
from Integrated DNA Technologies (Coralville, IA, USA). The 
target amplicons, named P0-P5, were selected to generate an 
accurate, complete sequence of the proximal promoter region 
using slight overlap between all adjacent amplicons (Figure 1B). 
Primer pairs P0 and P1 were designed to overlap with the pro-
moter sequence in which the msP Crhr1 polymorphisms were 
reported previously (31), with each amplicon containing one of 
the two known SNPs, to ensure successful sequencing. Primer 
sequences are provided in Table 1. Tail DNA was extracted and 
polymerase chain reaction (PCR) was carried out with all samples 
(~30 ng DNA/well) run on a single 96-well plate for each primer 
pair with seven wells reserved as no template controls. Sequencing 
reactions were run in both the forward and reverse directions. 
ABI trace files for all high quality sequencing results (defined as 
Phred scores > 20 for at least 75% of the sequence) were analyzed 
using Mutation Surveyor. Only mutations identified in analysis 
of both the forward and reverse direction sequencing reactions 
were considered to be real mutations. This approach for complete 
sequencing of the 2,300 bp upstream of the Crhr1 start codon was 
utilized for the strain comparison study.
Once it was clear which Crhr1 promoter nucleotide positions 
were likely to be altered in msP rats, a more targeted genotyping 
approach was taken for the rats involved in the behavioral studies. 
Because only 2 polymorphisms were observed across all rats in 
the strain comparison study, PCR primers were designed to target 
only the expected polymorphism sites, encompassing positions 
TaBle 2 | Prevalence of Crhr1 promoter polymorphisms in normal and alcohol-
preferring rat strains.
strain subjects Double snP expressing Prevalence (%)
Wistar 21 0 0.0
Indiana P 23 0a 0.0
Scr:sP 20 0 0.0
msP 25 17 68.0***
***p < 0.001 vs. all other groups.
aOne Indiana P rat (4.3%) displayed one but not both SNPs.
TaBle 1 | Crhr1 promoter primer sequences.
amplicon Forward primer reverse primer
P0 TGAAATCTGCTGCTT 
ACTGAGCCC
TGGGCAAGGAATGCG 
TACCTCTTA
P1 AGCACTTTCCCTCC 
AACAACCCTA
ACTCTGTTCTCAGCAC 
ACTGGACA
P2 ATCGCATGACCTAC 
AGCAACTCCA
TCTTGAGTACCCAGAA 
GCACCGAA
P3 TGGATCTTGTCCAG 
TGTGCTGAGA
AACTAAGCGTCTGTC 
TGTTTGGTC
P4 AGCTTCAGTGTCTC 
AGCACATCCT
AAGTCTGGTAGCCTTC 
TCCCGA
P5 AGAGGAGGGAGAAA 
GAGGAGGG
GCTTCAGAGATCCAGG 
TAGAGGACAT
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−2,092 and −1,835  bp relative to ATG start of Crhr1. Primer 
extension assays were performed using the Sequenom iPlex 
Gold reagent kit (San Diego, CA, USA), and extension products 
analyzed by mass spectrometry using a Sequenom Mass Array 
system. Base calls scored as “low probability” by the Sequenom 
software were not used in the final analysis.
home cage Food and alcohol intake
To explore further the functional significance of the Crhr1 
promoter genotype within the msP line, behavioral studies 
were performed in male msP rats (n = 79, weight range during 
experimentation 333–536 g, run in two cohorts of 32 and 47 rats, 
respectively). Rats were single-housed prior to the first alcohol 
access day to quantify home cage intake. To ascertain the relation 
of Crhr1 promoter genotype to home cage alcohol intake, msP 
rats were provided ad libitum concurrent, continuous access to 
10% alcohol (0.56  kcal/ml), water and food pellets (Mucedola 
4RF18, 2.6 kcal/g) until a stable baseline alcohol intake (5–7 g/
kg/day) was achieved (maximum 15% daily variation, reached 
in 3 weeks). Alcohol was prepared as a 10% (v/v) solution in tap 
water, and intake of both solutions and food was measured daily 
at 2, 4, 8, 12, and 24 h after the onset of the dark cycle. As no 
time-dependent differences were observed, data are presented 
as 7-day means of 24-h intake. All consumption measures are 
normalized to body weight to account for size differences in 
both caloric requirement and pharmacological efficacy. To 
assess differences in focus on alcohol as a fluid or caloric source, 
data are additionally presented as percent alcohol preference 
[100 × 10% (v/v) alcohol intake/total fluid intake] and as per-
cent calories derived from alcohol (100 × alcohol intake in kcal/
total kcal intake), per (17, 45). To further assess the impact of 
alcohol availability on chow intake, an additional group of rats 
from a rederivation of the msP line to separately breed AA and 
GG homozygous rats (35) was provided with ad libitum access 
to food pellets (Mucedola 4RF18, 2.6 kcal/g) and water in the 
absence of alcohol. Data are presented as 3-day means of 24-h 
food intake.
Data analysis
Strain differences in allele frequency were determined by 
Pearson’s chi square analysis. Alcohol intake, water intake and 
alcohol preference data were not normally distributed, possibly 
due to floor and ceiling effects, respectively, and thus were ana-
lyzed by ANOVA on ranks rather than ANOVA on raw values, 
with post  hoc comparisons performed using Dunn’s method. 
Body weight, food intake and caloric intake data were found 
to conform to normal distributions, and thus were analyzed by 
one-way ANOVA, with post  hoc comparisons via Tukey’s test. 
SigmaPlot 13.0 and Systat 13 (Chicago, IL, USA) software were 
used to perform the statistical analyses.
resUlTs
Crhr1 Promoter snP Prevalence in Wistar-
Derived alcohol-Preferring rat strains
Previously, two G-to-A base pair substitutions were reported 
2,097 and 1,836 bases upstream from the start codon in the Crhr1 
promoter region of most (85%) msP rats (31). Here, we sought 
to determine whether the A alleles are a common modification 
within Wistar-derived alcohol-preferring rat strains or are a 
distinguishing feature of msP rats that may account for their 
unique sensitivity to CRF1 antagonists under non-dependent 
conditions (9, 31, 36). Two statistically related polymorphisms 
were observed in the Crhr1 promoter in which both loci were 
either mutant variant (A) or wild-type (G) alleles. One SNP, from 
primer pair P0, was at position −2,092 relative to the ATG start 
site for Crhr1 on rat chromosome 10 (UCSC Genome Browser 
rat assembly November 2004: position 93,310,313 vs. ATG start 
at 93,312,405; rat assembly March 2012: position 91,951,378 vs. 
ATG start at 91,953,470; and rat assembly July 2014: position 
92,189,381 vs. ATG start at 92,191,473). The second SNP, from 
primer pair P1, was at position −1,835 (UCSC Genome Browser 
rat assembly November 2004 position 93,310,570; rat assembly 
March 2012, position 91,951,635; rat assembly July 2014, position 
92,189,638). The discrepancy in these SNP positions relative to 
the Crhr1 start codon, previously reported at 2,097 and 1,836 
bases upstream of transcription initiation (31), may be due to 
updates in the genome sequence since the initial publication of 
the SNPs but is consistent across the 2004, 2012, and 2014 UCSC 
Genome Browser assemblies. No additional high-frequency 
polymorphisms, defined as greater than 50% prevalence in any 
one or more of the strains studied, were identified in the promoter 
region. As shown in Table 2, the joint mutant variant A alleles 
at the polymorphic Crhr1 promoter loci were common in (68%) 
and exclusive to the msP line (χ2 = 53.80, p < 0.001). Post hoc 
comparisons demonstrated elevated prevalence of the polymor-
phisms in the msP strain as compared to all other strains tested 
5Logrip et al. Crhr1 SNPs and msP Alcohol Preference
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(all χ2’s > 19.06, all p’s < 0.001). Only one P rat carried the −2,092 
G-to-A SNP, but this was without the −1,836 SNP that invariably 
accompanied it in msP rats. Thus, the Crhr1 promoter A allele, 
with A at both polymorphic positions, was unique to the msP 
line.
relation of the Crhr1 Promoter snPs to 
alcohol intake and Preference
As the recently reported analysis of brain region-specific Crhr1 
expression was performed in rederived lines of GG and AA msP 
rats (32), it was of interest to determine whether the presence of 
G vs. A alleles had been associated with differences in alcohol 
consumption in the parent msP strain, in which elevated Crhr1 
expression was more widespread than observed in the red-
erived lines (31). msP rats from the parent strain were provided 
continuous two-bottle choice access to 10% alcohol vs. water in 
the home cage, and Crhr1 genotype determined after collection 
of all behavioral data. The A allele was present in approximately 
half of the msP rats in the drinking study (48.1%), with the AA 
genotype representing a minority of msP rats (11/79 = 13.9%) 
as compared to GA (27/79 = 34.2%) and GG (41/79 = 51.9%). 
As shown in Figure 2, weight-normalized alcohol consumption 
did not differ according to Crhr1 promoter allele (Figure 2A; 
one-way ANOVA on Ranks, H = 0.64, p = 0.73), similar to pub-
lished data for rederived GG vs. AA msP sublines (35). However, 
a significant elevation in alcohol preference was displayed by 
homozygous AA msP rats, relative to rats with only one A allele 
(GA) and rats homogyzous for the G allele (Figure 2B; one-way 
ANOVA on ranks, H = 8.11, p < 0.05). Preference differences 
reflected that AA rats consumed similar quantities of alcohol, 
but drank strikingly less water (Figure 2C; one-way ANOVA 
on ranks, H =  7.41, p <  0.05), without significant difference 
in total fluid intake (Figure 2D; one-way ANOVA, F2,76 = 0.71, 
p = 0.49).
AA rats also showed nonsignificant trends to eat less food 
(one-way ANOVA, F2,76  =  2.65, p  =  0.08), yet weigh more 
(F2,76 = 2.75, p = 0.07), as shown in Table 3. Because alcohol 
provides a source of calories, the increased preference and 
reduced food intake suggested a possible shift toward obtain-
ing calories from alcohol. To investigate this possibility, the 
percent of total calories obtained from alcohol was calculated. 
Crhr1 promoter genotype did not significantly alter the use 
of alcohol as a calorie source (Figure  2E, one-way ANOVA, 
F2,76  =  1.39, p  =  0.26), although genotype did significantly 
impact total caloric intake (Figure  2F, one-way ANOVA, 
F2,76 =  4.09, p <  0.05), with AA rats consuming significantly 
fewer calories than GA, but not GG, rats. These data suggest a 
role for Crhr1 promoter genotype in regulating caloric intake, 
but the possibility remained that alcohol availability might 
alter food intake. To assess Crhr1 promoter genotype effects 
on food intake under baseline conditions, when alcohol was 
not available, food consumption was measured in AA and GG 
rats from the rederived msP lines (35) over a 3-day period. As 
shown in the bottom half of Table 3, AA and GG rats of the 
rederived lines consumed similar quantities of food (one-way 
ANOVA, F1,15 = 0.45, p = 0.51) and did not differ in body weight 
(one-way ANOVA, F1,15 = 0.04, p = 0.84).
DiscUssiOn
The present data demonstrate that the A allele polymorphisms in 
the Crhr1 promoter region are specific to msP rats and likely play 
a minor role in promoting alcohol drinking under unstressed 
conditions. The two previously described (31) G-to-A SNPs were 
confirmed in the Crhr1 promoter of msP rats, but were not found 
to be common markers of high alcohol intake, as they were not 
observed in other alcohol-preferring strains selectively bred from 
Wistar stock (P, Scr:sP). Rather, the presence of A nucleotides at 
both polymorphic loci was nearly exclusively restricted to the msP 
line, with only one rat (4%) from the Indiana P line presenting an 
A nucleotide at one polymorphic locus, but not both, on a single 
allele. Within the msP line, the mutant A variant allele was associ-
ated with decreased water intake, lower total caloric intake, and 
elevated alcohol preference, although preference differences may 
have minimal physiological impact as all preference scores were 
extremely high regardless of genotype, and alcohol consumption 
did not differ. Recently, the msP line was rederived to generate 
parallel lines homozygous for A alleles (AA) or wild-type G alleles 
(GG) (35). In the rederived msP AA rats, elevated alcohol prefer-
ence was visible but did not reach significance, except under con-
ditions of heightened stress (35). Similarly, we observed reduced 
caloric intake in AA rats from the parent strain that was not seen 
in rederived msP AA rats, when assessed in the absence of alcohol 
availability. These data suggest that the alcohol preference and 
caloric intake phenotypes may either require additional interact-
ing gene variants possessed by the parent, but not rederived, 
line, be determined (partly) independent of the Crhr1 promoter 
polymorphisms, or be triggered by differential life experiences, 
like stressors, that could have differentially affected a specific 
cohort and would be hypothesized to increase Crhr1 expression 
to a greater degree in msP AA rats (35). In the rederived rats, 
both GG and AA rats displayed elevated amygdala Crhr1 mRNA 
levels relative to Wistar controls, whereas Crhr1 levels in the bed 
nucleus of the stria terminalis (BNST) were higher in AA vs. GG 
rats (32). Collectively, the data demonstrate that the mutant A 
variant allele at the polymorphic Crhr1 promoter loci is restricted 
to msP rats and may be related to elevated alcohol preference, 
but it is not sufficient to promote greater alcohol drinking or 
amygdala CRF1 expression observed in the msP rat line under 
unstressed conditions (31). However, the polymorphisms have 
been associated with increased stress sensitivity (32, 46) and 
heightened response to CRF1 antagonism (31, 34, 35) in both 
the parent and rederived lines, suggesting that both the drinking 
phenotype and the CRF1 antagonist sensitivity may relate to the 
significantly elevated anxiety-like behavior generally displayed 
by msP rats (32, 46). While operant self-administration was 
elevated by the pharmacological stressor yohimbine in both GG 
and AA rats, the contribution of the gene variants to drinking 
under stress remains to be determined.
Crhr1 Polymorphisms and the regulation 
of crF1 expression
Hansson et  al. originally reported 2 G-to-A substitutions in the 
promoter region of Crhr1 of msP rats on one or both gene loci in 
a majority (85%) of msP rats (31). The present study found lower 
TaBle 3 | Food intake and body weight of msP rats with home cage two-bottle 
choice access to 10% alcohol.
Promoter genotype Food (kcal) Weight (g)
10% alcohol available concurrently
AA 117.8 ± 2.4 452.7 ± 6.5
GA 128.4 ± 2.7 421.3 ± 6.8
GG 124.8 ± 2.1 433.4 ± 6.6
no alcohol available
AA 57.3 ± 1.7 415.4 ± 8.1
GG 54.3 ± 1.8 417.7 ± 8.0
Food intake and body weight expressed as mean ± SEM.
FigUre 2 | Marchigian substrain of Sardinian alcohol-preferring (msP) rats carrying the Crhr1 promoter polymorphisms on both alleles show altered alcohol 
preference, water intake and calories consumed. Home cage fluid intake and preference were determined for msP rats with known Crhr1 promoter genotypes 
consuming 10% alcohol under a two-bottle choice paradigm. Genotype-specific effects were assessed for (a) alcohol intake, (B) alcohol preference [(alcohol 
consumed)/(total fluid intake)], (c) water intake, (D) total fluid intake, (e) percent calories obtained from alcohol [(alcohol calories consumed)/(total caloric intake)], 
and (F) total calorie intake. Data are expressed as mean ± SEM daily measurements averaged across 7 days of stable intake. Overlaid on histograms are individual 
subjects’ data points to demonstrate the variability among subjects in each group. *p < 0.05 vs. GG and GA, $p < 0.05 vs. GA. n = 11 AA, 27 GA, 41 GG.
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frequency of the A nucleotides, occurring in 68% of msP rats in the 
strain survey and 48% of msP rats in the behavior cohort. These fre-
quency differences may result from random selection of rats from 
the population for the various experiments, as Crhr1 promoter 
genotype was not determined until the conclusion of experiments, 
or from genetic drift in the frequency of the AA loci in the msP 
parent line over time. The rederived parallel AA and GG msP lines 
now allow for direct assessment of the behavioral impact of the 
promoter polymorphism (35), particularly helping to delineate the 
phenotypes observed in the parent msP line that may have resulted 
from genes other than Crhr1 cosegregating with AA status.
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In addition to the reduced frequency of the dual poly-
morphism in the current msP cohort, slight differences in the 
locations of both SNPs were identified in the genetic analysis, 
with one located 1,835  bp (rather than 1,836  bp) upstream of 
the receptor start codon, and the second SNP at 2,092 bp (rather 
than 2,097  bp) upstream. This discrepancy in position may 
reflect modification of the genome sequence since the original 
identification of the polymorphisms. Both loci lie well outside 
the proximal core promoter region (47), which could explain 
the apparent lack of involvement of the variant alleles in basal 
amygdala Crhr1 expression (31, 32). However, in the rederived 
msP lines, Crhr1 expression in the BNST was higher in AA than 
in GG or Wistar controls, suggesting that the polymorphism can 
affect Crhr1 gene expression in a brain region-specific manner, 
despite the distance from the core promoter region. Distal DNA 
regions as far away as 100 kb can alter transcription via various 
mechanisms, resulting in enhancement, repression or insulation 
of transcription factor activity (47–50). Such effects can occur 
via looping of the intervening DNA sequence that apposes the 
distal upstream sequence to the proximal promoter (49, 51), as 
well as by regulation of DNA availability through methylation 
(50). Despite these possible mechanisms by which distal Crhr1 
promoter regions may regulate its expression, at present the data 
are largely lacking for genotype differences in basal Crhr1 levels. 
Nonetheless, distal regions of the Crhr1 promoter may provide a 
site for experience-based modulation of Crhr1 transcription that 
would confer the differential sensitivity to CRF1 antagonism and 
stress-induced reinstatement observed in AA msP rats (35).
One mechanism by which stress may alter CRF1 function, via 
altered receptor expression, involves changes in distal promoter 
methylation status. The Crhr1 promoter region lies within a CpG 
island, and behavioral experiences that alter anxiety-like behavior 
have been shown to increase methylation on one CpG site located 
1,348 bases upstream of the Crhr1 translation start in the amyg-
dala (52). Recently, stress-related changes in gene methylation 
status and expression of another receptor (Oprl1) were shown in 
msP rats using a stress paradigm that increased msP rats’ alcohol 
consumption (53), indicating that stressors that exacerbate alco-
hol intake in msPs might accomplish this via altered methylation, 
and thereby expression, of specific gene targets. Since AA msP 
rats are anticipated to be more susceptible to stress-induced eleva-
tions in drinking based on yohimbine exacerbation of operant 
alcohol self-administration (35), stress-related increases in Crhr1 
promoter methylation might differentially impact Crhr1 gene 
expression in AA vs. GG msP rats. Together these data highlight 
the possible involvement of distal regions of the Crhr1 promoter 
as putative sites of stress-related regulation of CRF1 expression, 
and point to the identification of the molecular mechanisms by 
which the variant A alleles may confer increased sensitivity to 
stress and CRF1 modulation of alcohol self-administration as an 
important focus to uncover new therapeutic avenues for alcohol 
dependence.
crF1 regulation of alcohol intake
Increased activation of the CRF system is evident in the progres-
sion to substance dependence, including for alcohol [reviewed 
in Ref. (54)]. Pharmacological and genetic studies specifically 
implicate activation of extended amygdala CRF1 receptors in 
mediating the excessive alcohol self-administration resulting 
from chronic intermittent exposure (7, 8) or access to alcohol 
sufficient to produce excessive (10) or binge-like (11, 15–17) 
drinking. Before CRF1 antagonists were found to reduce alcohol 
self-administration in nondependent msP rats (31), recruitment 
of the CRF system had been conceptualized, even within alcohol-
preferring rat lines (9, 36), as a mechanism of transition to 
alcohol dependence that resulted from chronic intermittent alco-
hol exposure. Indeed, chronic intermittent exposure to alcohol 
in Wistar rats leads to alcohol dependence and increased alcohol 
intake in association with increased extracellular CRF levels 
during withdrawal (6), depletion of amygdala CRF tissue content 
(3, 55), elevated CRF1 expression in the basolateral and medial 
amygdala (56), and potentiation of GABA and glutamate release 
in the central amygdala (57, 58). msP rats also express elevated 
CRF1, even under alcohol-naïve conditions (31), and show ele-
vated function of the GABA and glutamate systems in the central 
amygdala (46, 59, 60). Binge-like DID alcohol consumption in 
C57BL/6J mice also altered CRF levels and electrophysiological 
properties of the central amygdala (15), but in contrast to alcohol 
dependence and msP findings, CRF immunoreactivity increased, 
presynaptic GABA release was unchanged, and CRF lost the abil-
ity to enhance evoked GABAergic currents after DID. Thus, CRF1 
antagonists’ ability to similarly reduce alcohol consumption in 
multiple models of heightened alcohol intake may arise from dif-
ferential adaptation at the neuronal level based on alcohol access 
parameters utilized and stimuli producing heightened alcohol 
intake (7, 8, 11, 12, 16, 34, 61–63). The regulation of alcohol intake 
by CRF1 encompasses its activation by both CRF and urocortin-1, 
which has been shown to specifically regulate escalating, but not 
controlled, alcohol intake (45). How urocortin-1 impacts alcohol 
intake in preferring rat lines, including msP rats, and whether 
this might be a site of neuronal adaptation yielding high alcohol 
intake remain to be determined, although greater density of uro-
cortin-1 fibers across multiple preferring, vs. non-preferring, rat 
lines (64) suggest likely contribution of urocortin-1 to the high 
drinking phenotype. Surprisingly, while the msP (27), P (41), and 
Scr:sP (9, 40, 65) strains of alcohol-preferring rats each display 
high levels of alcohol intake, only msP rats are sensitive to CRF1 
antagonists in the absence of experimentally induced alcohol 
dependence (9, 27, 35, 36). The alcohol dependent-like neuronal 
activity profiles displayed in the central amygdala of msP rats 
(46, 59, 60), which may contribute to the rats’ increased anxiety-
like phenotype (32, 46), are of particular interest for further 
examination as a basis for msP rats’ high alcohol preference.
Human studies support the involvement of CRF/CRF1 in 
alcohol dependence (23, 66), despite the fact that clinical trials for 
CRF1 antagonists have been unsuccessful to date (23). Elevated 
CRF levels were seen in the cerebrospinal fluid of recently with-
drawn alcoholics (67). Similar to the Crhr1 promoter variants 
seen in the msP line, human CRHR1 SNPs have been associated 
with facets of alcohol dependence. Variant CRHR1 haplotypes in 
adolescents predicted future problem drinking patterns, includ-
ing binge drinking and lifetime prevalence of intoxication and 
alcohol dependence (68). CRHR1 SNPs also predicted higher lev-
els of alcohol consumption in already dependent individuals (68) 
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and associated with reduced P300 levels, which are observed in 
alcoholics (69). CRHR1 SNPs predicted greater future drinking in 
relation to recent stress history (70), implicating CRF1 systems 
in stress-induced drinking, consistent with observations in msP 
rats (31, 35), C57BL/6J mice (12) and Crhr1 knockout mice (71). 
Genetic associations of CRF signaling to alcohol phenotypes in 
humans is not restricted to CRHR1, because several studies link 
genetic variants in CRHBP, which encodes the CRF-binding 
protein, to features of alcohol dependence. Polymorphisms in 
CRHBP, which is hypothesized to modulate the amount of CRF 
or urocortin-1 available to interact with its receptors, have been 
related to decreased EEG alpha wave power (72), a feature observed 
in alcoholics (72, 73), and are more prevalent in alcoholics with 
comorbid anxiety disorders (74). CRHBP polymorphisms have 
also been related to severity of stress-induced alcohol craving 
(75) and have been hypothesized to impact anxiety or drinking 
in alcohol-dependent individuals (76). Individual CRHBP and 
CRHR1 SNPs have been shown to coordinately predict alcohol 
use disorder comorbidity in a panel of schizophrenic patients 
(77). Importantly, Ribbe et al. (77) demonstrated elevated levels 
of CRHR1 mRNA relative to CRHBP mRNA in blood from 
individuals carrying the dual polymorphism, suggesting that 
CRF1 activation by CRF or urocortin-1 predominates over CRF/
CRF-BP or urocortin-1/CRF-BP interactions in individuals with 
high predisposition to develop alcohol use disorders. Additional 
gene variants of CRHR1 and CRHBP have been associated with 
various mood and anxiety disorders as well as alcohol use disorders 
[reviewed in Ref. (23)], implicating the CRF1 system in various 
mental illnesses characterized by emotional dysregulation. These 
human findings resonate with the present data in suggesting a 
key role for CRF1 signaling in some forms of alcoholism, perhaps 
particularly those with stress history or comorbid anxiety.
Crhr1 Promoter genotype and  
caloric intake
Expression of the dual polymorphism in the Crhr1 promoter 
was associated with increased alcohol preference, although 
preference levels were near ceiling in all genotypes and differ-
ences appear to result from decreased water intake rather than 
significantly increased alcohol intake per se. However, msP AA 
rats also consumed significantly less total calories than rats of the 
GA genotype, and tended to consume less food than both GG 
and GA genotype rats. While these results initially suggested a 
possible shift in calorie focus toward alcohol for AA msP rats—as 
observed in human alcoholics who transition toward consuming 
half their daily calories in alcohol (78, 79)—direct assessment of 
this possibility showed no significant genotype effects on percent 
of calories obtained from alcohol. Instead, these results suggest 
that Crhr1 promoter genotype plays a more general role in 
regulating caloric intake that may not be specific to alcohol. Both 
CRF1 agonist (80) and antagonist (17) treatments reduced food 
intake, as did genetic deletion of Crhr1 (17), further support-
ing a general role for CRF1 in regulating intake nonspecifically 
to alcohol. Interestingly, deletion of urocortin-1 only reduced 
escalated alcohol intake, but not food or water intake (45), dem-
onstrating the capacity for the CRF system to specifically regulate 
dysregulated alcohol consumption in the absence of global intake 
modulation. The lack of differential caloric intake in rederived 
msP rats in the absence of alcohol, as well as the fact that caloric 
intake only differed significantly between AA and GA msP 
rats, suggests that Crhr1 promoter genotype does not globally 
modulate consumption but rather may impact intake in a more 
directed fashion, whether in the presence of alcohol or under 
conditions of elevated stress that are proposed to increase Crhr1 
expression. Determining the relationship between CRF1 system 
activity, stress, and alcohol consumption, particularly a possible 
shift toward the use of alcohol as an alternative calorie source, in 
the msP rat line remain important future lines of investigation.
cOnclUsiOn
Here, we show that two joint variants in the distal promoter 
region of Crhr1 are restricted to the msP line, relative to other 
alcohol-preferring strains, and associate with increased alcohol 
preference, although all rats display extremely high preference, 
as well as decreased water intake and reduced total caloric con-
sumption. In light of the growing body of literature demonstrat-
ing associations between polymorphisms in human CRHR1 and 
CRFBP and comorbid stress/anxiety and AUD, the present data 
support a continued focus on CRF1 as a therapeutic target not 
for the global AUD population, but rather for a subset of AUD 
individuals, particularly those with stress-related comorbidities. 
A pharmacogenomic approach that accounts for CRF system 
polymorphisms may have particular utility for the treatment of 
alcohol use disorders.
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